Flu

New insights on influenza genome packaging could guide strategies for interfering with the virus's life cycle and ability to cause infection. Read More

From Vanderbilt Magazine: James Crowe, director of the Vanderbilt Vaccine Center, hopes to create a universal flu vaccine--permanently eliminating the problem of ineffective or under-effective annual flu shots. Read More

Neighborhood determinants – represented by census tract data – contribute to the risk of influenza hospitalization and could be used to guide interventions such as vaccinations to high-risk areas. Read More

High dose flu vaccine boosts the immune response in older adults by increasing activation of certain immune cells. Read More

Vanderbilt investigators have discovered how human antibodies induced during testing of an experimental “bird flu” vaccine kill the virus. Read More

A study appearing in the January edition of Pediatrics, led by researchers at Vanderbilt University Medical Center, looks at how Nashville children ages 6 months through 5 years fared over 11 consecutive flu seasons concluding in 2010-11. Read More

Compounds developed at Vanderbilt University may offer a new way to block influenza infection. Read More

Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia. Read More

Vanderbilt research shows that human antibodies to the natural strain of H5N1 also protected against a dangerous lab-created airborne strain developed several years ago by scientists in the Netherlands and at the University of Wisconsin. Read More

Studies of Flu Tool, a computer application that guides health care decision-making, suggests that patients are willing to use these types of resources. Read More